Plus Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q
Stock Information for Organogenesis Holdings Inc.
Loading
Please wait while we load your information from QuoteMedia.